Screening attendance, prevalence and severity of diabetic retinopathy (DR) in a cohort of patients with diabetes mellitus secondary to chronic pancreatitis (DMsCP) in Northern Ireland

Introduction This study investigated Northern Ireland Diabetic Eye Screening Programme (NIDESP) attendance and diabetic retinopathy (DR) prevalence/severity in patients with diabetes mellitus secondary to chronic pancreatitis (PwDMsCP).Research design and methods Medical/NIDESP records for all PwDMs...

Full description

Saved in:
Bibliographic Details
Main Authors: Tunde Peto, Nicola Quinn, Philip C Johnston, Catherine Jamison, Rossella D’Aloisio, Laura Nicole Cushley
Format: Article
Language:English
Published: BMJ Publishing Group 2021-03-01
Series:BMJ Open Diabetes Research & Care
Online Access:https://drc.bmj.com/content/9/1/e002267.full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850124338095718400
author Tunde Peto
Nicola Quinn
Philip C Johnston
Catherine Jamison
Rossella D’Aloisio
Laura Nicole Cushley
author_facet Tunde Peto
Nicola Quinn
Philip C Johnston
Catherine Jamison
Rossella D’Aloisio
Laura Nicole Cushley
author_sort Tunde Peto
collection DOAJ
description Introduction This study investigated Northern Ireland Diabetic Eye Screening Programme (NIDESP) attendance and diabetic retinopathy (DR) prevalence/severity in patients with diabetes mellitus secondary to chronic pancreatitis (PwDMsCP).Research design and methods Medical/NIDESP records for all PwDMsCP attending the pancreatic diabetes clinic were analyzed in 2017 (n=78) and 2019 (n=94).Results Between 2017 and 2019, those without DR decreased (76% to 63%); mild non-proliferative DR (NPDR), severe NPDR and PDR were found in 30%, 2% and 5%, respectively (previously 18%, 4%, 2%); diabetic maculopathy (DMac) was present in 12% (previously 10%). There was no significant difference between worst-eye DR/DMac grade and HbA1c, gender, body mass index, pancreatitis etiology and screening attendance (p>0.05). Patients with proliferative DR had longer diabetes and pancreatitis duration than DR-free patients (both p=0.001).Conclusions DR prevalence was similar in PwDMsCP and patients with type 2 diabetes of similar disease duration. This work demonstrates the importance of reaching all patients for establishing DR severity reliably and to provide accessible, equitable care to PwDMsCP.
format Article
id doaj-art-37041aa67d074f918d9253feab60d98b
institution OA Journals
issn 2052-4897
language English
publishDate 2021-03-01
publisher BMJ Publishing Group
record_format Article
series BMJ Open Diabetes Research & Care
spelling doaj-art-37041aa67d074f918d9253feab60d98b2025-08-20T02:34:20ZengBMJ Publishing GroupBMJ Open Diabetes Research & Care2052-48972021-03-019110.1136/bmjdrc-2021-002267Screening attendance, prevalence and severity of diabetic retinopathy (DR) in a cohort of patients with diabetes mellitus secondary to chronic pancreatitis (DMsCP) in Northern IrelandTunde Peto0Nicola Quinn1Philip C Johnston2Catherine Jamison3Rossella D’Aloisio4Laura Nicole Cushley5Centre for Public Health, Queen`s University Belfast Faculty of Medicine Health and Life Sciences, Belfast, UKBelfast Ophthalmic Reading Centre, Centre for Public Health, Queen’s University Belfast, Belfast, UKThe Belfast Pancreatic Diabetes Clinic, Belfast City Hospital Health and Social Services Trust, Belfast, UKBelfast Ophthalmic Reading Centre, Centre for Public Health, Queen’s University Belfast, Belfast, UKOphthalmology Clinic, Department of Medicine and Science of Ageing, University G d`Annunzio Chieti-Pescara, Chieti, ItalyBelfast Ophthalmic Reading Centre, Centre for Public Health, Queen’s University Belfast, Belfast, UKIntroduction This study investigated Northern Ireland Diabetic Eye Screening Programme (NIDESP) attendance and diabetic retinopathy (DR) prevalence/severity in patients with diabetes mellitus secondary to chronic pancreatitis (PwDMsCP).Research design and methods Medical/NIDESP records for all PwDMsCP attending the pancreatic diabetes clinic were analyzed in 2017 (n=78) and 2019 (n=94).Results Between 2017 and 2019, those without DR decreased (76% to 63%); mild non-proliferative DR (NPDR), severe NPDR and PDR were found in 30%, 2% and 5%, respectively (previously 18%, 4%, 2%); diabetic maculopathy (DMac) was present in 12% (previously 10%). There was no significant difference between worst-eye DR/DMac grade and HbA1c, gender, body mass index, pancreatitis etiology and screening attendance (p>0.05). Patients with proliferative DR had longer diabetes and pancreatitis duration than DR-free patients (both p=0.001).Conclusions DR prevalence was similar in PwDMsCP and patients with type 2 diabetes of similar disease duration. This work demonstrates the importance of reaching all patients for establishing DR severity reliably and to provide accessible, equitable care to PwDMsCP.https://drc.bmj.com/content/9/1/e002267.full
spellingShingle Tunde Peto
Nicola Quinn
Philip C Johnston
Catherine Jamison
Rossella D’Aloisio
Laura Nicole Cushley
Screening attendance, prevalence and severity of diabetic retinopathy (DR) in a cohort of patients with diabetes mellitus secondary to chronic pancreatitis (DMsCP) in Northern Ireland
BMJ Open Diabetes Research & Care
title Screening attendance, prevalence and severity of diabetic retinopathy (DR) in a cohort of patients with diabetes mellitus secondary to chronic pancreatitis (DMsCP) in Northern Ireland
title_full Screening attendance, prevalence and severity of diabetic retinopathy (DR) in a cohort of patients with diabetes mellitus secondary to chronic pancreatitis (DMsCP) in Northern Ireland
title_fullStr Screening attendance, prevalence and severity of diabetic retinopathy (DR) in a cohort of patients with diabetes mellitus secondary to chronic pancreatitis (DMsCP) in Northern Ireland
title_full_unstemmed Screening attendance, prevalence and severity of diabetic retinopathy (DR) in a cohort of patients with diabetes mellitus secondary to chronic pancreatitis (DMsCP) in Northern Ireland
title_short Screening attendance, prevalence and severity of diabetic retinopathy (DR) in a cohort of patients with diabetes mellitus secondary to chronic pancreatitis (DMsCP) in Northern Ireland
title_sort screening attendance prevalence and severity of diabetic retinopathy dr in a cohort of patients with diabetes mellitus secondary to chronic pancreatitis dmscp in northern ireland
url https://drc.bmj.com/content/9/1/e002267.full
work_keys_str_mv AT tundepeto screeningattendanceprevalenceandseverityofdiabeticretinopathydrinacohortofpatientswithdiabetesmellitussecondarytochronicpancreatitisdmscpinnorthernireland
AT nicolaquinn screeningattendanceprevalenceandseverityofdiabeticretinopathydrinacohortofpatientswithdiabetesmellitussecondarytochronicpancreatitisdmscpinnorthernireland
AT philipcjohnston screeningattendanceprevalenceandseverityofdiabeticretinopathydrinacohortofpatientswithdiabetesmellitussecondarytochronicpancreatitisdmscpinnorthernireland
AT catherinejamison screeningattendanceprevalenceandseverityofdiabeticretinopathydrinacohortofpatientswithdiabetesmellitussecondarytochronicpancreatitisdmscpinnorthernireland
AT rosselladaloisio screeningattendanceprevalenceandseverityofdiabeticretinopathydrinacohortofpatientswithdiabetesmellitussecondarytochronicpancreatitisdmscpinnorthernireland
AT lauranicolecushley screeningattendanceprevalenceandseverityofdiabeticretinopathydrinacohortofpatientswithdiabetesmellitussecondarytochronicpancreatitisdmscpinnorthernireland